These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664 [Abstract] [Full Text] [Related]
10. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M, Stapleton PP, Freeman TA, Gaughan JP, Matsuda T, Daly JM. J Am Coll Surg; 2004 Sep 01; 199(3):428-35. PubMed ID: 15325613 [Abstract] [Full Text] [Related]
11. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J. J Urol; 2003 Nov 01; 170(5):2036-9. PubMed ID: 14532848 [Abstract] [Full Text] [Related]
12. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep 01; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
13. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Ding XZ, Tong WG, Adrian TE. Anticancer Res; 2000 Sep 01; 20(4):2625-31. PubMed ID: 10953335 [Abstract] [Full Text] [Related]
14. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Liu XH, Yao S, Kirschenbaum A, Levine AC. Cancer Res; 1998 Oct 01; 58(19):4245-9. PubMed ID: 9766645 [Abstract] [Full Text] [Related]
15. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ. Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772 [Abstract] [Full Text] [Related]
16. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS. Clin Cancer Res; 2001 May 15; 7(5):1410-8. PubMed ID: 11350912 [Abstract] [Full Text] [Related]
17. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN. Clin Cancer Res; 2001 Oct 15; 7(10):2998-3005. PubMed ID: 11595687 [Abstract] [Full Text] [Related]
18. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q. Cancer Invest; 2008 May 15; 26(4):333-7. PubMed ID: 18443952 [Abstract] [Full Text] [Related]
19. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL. J Surg Res; 1999 Jan 15; 81(1):101-7. PubMed ID: 9889067 [Abstract] [Full Text] [Related]